Comment
doi: 10.1056/NEJMc1702531.
Bezlotoxumab and Recurrent Clostridium difficile Infection
Affiliations
- PMID: 28425276
- DOI: 10.1056/NEJMc1702531
Item in Clipboard
Comment
Bezlotoxumab and Recurrent Clostridium difficile Infection
N Engl J Med.
.
Free article
No abstract available
Comment in
-
Bezlotoxumab and Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Apr 20;376(16):1594-6. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423298 No abstract available.
-
Bezlotoxumab and Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Apr 20;376(16):1596. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423300 No abstract available.
Comment on
-
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. N Engl J Med. 2017. PMID: 28121498 Clinical Trial.
Similar articles
-
Bezlotoxumab and Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Apr 20;376(16):1596. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423300 No abstract available.
-
Bezlotoxumab and Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Apr 20;376(16):1594. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423299 No abstract available.
-
Bezlotoxumab and Recurrent Clostridium difficile Infection.N Engl J Med. 2017 Apr 20;376(16):1594-6. doi: 10.1056/NEJMc1702531. N Engl J Med. 2017. PMID: 28423298 No abstract available.
-
Pathogenesis and treatment of Clostridium difficile infection.Postgrad Med J. 2005 Jun;81(956):367-9. doi: 10.1136/pgmj.2004.028480. Postgrad Med J. 2005. PMID: 15937201 Free PMC article. Review.
-
[Oncologic aspects of Clostridium difficile].Orv Hetil. 2016 Jul;157(28):1110-6. doi: 10.1556/650.2016.30463. Orv Hetil. 2016. PMID: 27397423 Review. Hungarian.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
